---
title: "Quantification tools for a novel tau PET marker in a rare neurological disease: 18F-PI-2620 in progressive supranuclear palsy"
euct_id: 2023-508718-40-00
phase: Phase 4
status: Recruiting
sponsor: Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer
canonical_url: "https://parkinsonspathways.com/trials/eu/2023-508718-40-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2023-508718-40-00"
ctis_last_updated: "2025-04-24T21:35:03.272160579"
source: EU Clinical Trials Information System (CTIS)
---
# Quantification tools for a novel tau PET marker in a rare neurological disease: 18F-PI-2620 in progressive supranuclear palsy

**EU CT Number:** [2023-508718-40-00](https://euclinicaltrials.eu/ctis-public/view/2023-508718-40-00)

## Key Facts

- **Phase:** Phase 4
- **Status:** Recruiting
- **Sponsor:** Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer
- **Start Date:** 2024-06-30
- **Completion Date:** 2026-12-31
- **Conditions:** Progressive supranuclear palsy, Parkinson's disease, Disease Parkinson's
- **Interventions:** [18F]PI-2620

## Member States

Trial is authorized in 1 member state: Spain.

## Sites (1)

- Hospital Clinic De Barcelona, Barcelona, Spain

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Progressive supranuclear palsy; Parkinson's disease; Disease Parkinson's
Age groups: elderly 65+, adults 18-64
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2023-508718-40-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2023-508718-40-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2023-508718-40-00*